Alcoholic beverages are widely consumed all over the
world, but
continuous ethanol exposure leads to hepatic steatosis that, without
proper treatment, will later develop into severe liver disorders.
In this study, we investigated the potential protective effect of
tangeretin, a flavonoid derived from citrus peel, against alcoholic
fatty liver. The in vivo effects of tangeretin were
analyzed by oral intake in a chronic-binge alcohol feeding C57BL/6j
mouse model, while the underlying mechanism was explored by in vitro studies performed on ethanol-treated hepatic AML-12
cells. Ethanol feeding increased the serum alanine aminotransferase
and aspartate aminotransferase levels, the liver weight, and the serum
and liver triacylglycerol contents, whereas 20 and 40 mg/kg tangeretin
treatment promoted a dose-dependent suppression of these effects.
Interestingly, tangeretin prevented increases in the liver oxidative
stress level and protected the hepatocyte mitochondria from ethanol-induced
morphologic abnormalities. A mechanistic study showed that 20 μM
tangeretin treatment activated mitophagy through an AMP-activated
protein kinase (AMPK)–uncoordinated 51-like kinase 1 (Ulk1)
pathway, thereby restoring mitochondria respiratory function and suppressing
steatosis. By contrast, blocking the AMPK–Ulk1 pathway with
compound C reversed the hepatoprotective effect of tangeretin. Overall,
tangeretin activated mitophagy and protected against ethanol-induced
hepatic steatosis through an AMPK–Ulk1-dependent mechanism.